| Literature DB >> 24917593 |
Gwen MacDonald1, Ivan Nalvarte1, Tatiana Smirnova1, Manuela Vecchi2, Nicola Aceto3, Arno Dolemeyer4, Anna Frei3, Susanne Lienhard1, Jeffrey Wyckoff1, Daniel Hess1, Jan Seebacher1, Jeremy J Keusch1, Heinz Gut1, Daniele Salaun5, Giovanni Mazzarol6, Davide Disalvatore7, Mohamed Bentires-Alj1, Pier Paolo Di Fiore8, Ali Badache5, Nancy E Hynes9.
Abstract
Memo is an evolutionarily conserved protein with a critical role in cell motility. We found that Memo was required for migration and invasion of breast cancer cells in vitro and spontaneous lung metastasis from breast cancer cell xenografts in vivo. Biochemical assays revealed that Memo is a copper-dependent redox enzyme that promoted a more oxidized intracellular milieu and stimulated the production of reactive oxygen species (ROS) in cellular structures involved in migration. Memo was also required for the sustained production of the ROS O2- by NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) oxidase 1 (NOX1) in breast cancer cells. Memo abundance was increased in >40% of the primary breast tumors tested, was correlated with clinical parameters of aggressive disease, and was an independent prognostic factor of early distant metastasis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24917593 DOI: 10.1126/scisignal.2004870
Source DB: PubMed Journal: Sci Signal ISSN: 1945-0877 Impact factor: 8.192